Stock News•1 week ago
AL-S Pharma Appoints Harry Welten as Chief Executive Officer
AL-S Pharma named Harry Welten CEO, succeeding Michael Salzmann, after reporting positive Phase 2 topline results for its lead ALS antibody AP-101.
MarketLens
What Does Alvotech's Executive Team Change Signify
5 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Why Did Atlassian (TEAM) Stock Stumble Today
6 months ago
Category
You may also like
Stock News•3 weeks ago
Evotec Announces Chief Scientific Officer Transition
Evotec SE said Chief Scientific Officer Dr. Cord Dohrmann will step down effective September 30, 2026, and a search for a successor is ongoing. The CSO transition removes a senior scientific leader as...
Stock News•2 months ago
Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts
Alvotech's Hold rating persists after missed H1 2026 earnings and regulatory hurdles, though FDA CRLs for AVT05/AVT06 were resolved via manufacturing fixes. BLAs resubmitted, targeting multiple approv...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•53 minutes ago
Amazon cloud capacity sold out through 2027, CEO Jassy says
Stock News•1 hour ago
GE Vernova (GEV) Suffers a Larger Drop Than the General Market: Key Insights
Stock News•2 hours ago
Hottest toy for Christmas? Nvidia CEO plays with adorable Microduck robots, 20,000 sell
Stock News•2 hours ago
Turmoil hits AI buildout as neoclouds face pressure, credit risks mount and Solidigm pulls IPO
Stock News•3 hours ago